Literature DB >> 17339766

Palliative intravenous cisplatin treatment for concurrent peritoneal and pleural mesothelioma in a dog.

Kyoung-Won Seo1, Ul-Soo Choi, Yun-Chan Jung, Su-Ji Hong, Ye-Eun Byeun, Min-Soo Kang, B Pachrin, Wan-Hee Kim, Cheol-Yong Hwang, Dae-Yong Kim, Hwa-Young Youn, Chang-Woo Lee.   

Abstract

A 10-year-old Maltese dog was presented with abdominal distention and dyspnea. Cytological examination of pleural and peritoneal effusion was suggestive of malignant effusion of glandular origin. Numerous, multifocal, tan to white nodules were disseminated throughout the surface of the abdominal organs and peritoneum at biopsy. Histologically, the tumors were revealed to be an epithelial type of mesothelioma. Neoplastic cells co-expressed cytokeratin and vimentin. Intravenous administration of cisplatin was chosen as the treatment. During treatment, the dog's overall body condition improved and the clinical signs were relieved without significant side effects. The survival time from diagnosis to sudden death by unknown cause was 153 days.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339766     DOI: 10.1292/jvms.69.201

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumors.

Authors:  Shuang Cai; Ti Zhang; W C Forrest; Qiuhong Yang; Chad Groer; Eva Mohr; Daniel J Aires; Sandra M Axiak-Bechtel; Brian K Flesner; Carolyn J Henry; Kimberly A Selting; Deborah Tate; Jeffrey A Swarz; Jeffrey N Bryan; M Laird Forrest
Journal:  Am J Vet Res       Date:  2016-09       Impact factor: 1.156

2.  Bacterial pleuritis with thickened mesothelial hyperplasia in a young beagle dog.

Authors:  Naoaki Yamada; Satomi Hashimoto; Yuki Tomonari; Hiroko Kokoshima; Takuya Doi; Junko Sato; Yumi Wako; Minoru Tsuchitani
Journal:  J Toxicol Pathol       Date:  2013-10-15       Impact factor: 1.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.